{"id":16210,"date":"2015-12-18T00:03:19","date_gmt":"2015-12-17T23:03:19","guid":{"rendered":"http:\/\/alcyon:7777\/transgene170914\/?p=16210"},"modified":"2025-11-12T16:37:35","modified_gmt":"2025-11-12T15:37:35","slug":"tg4010-immunotherapy-and-first-line-chemotherapy-for-advanced-non-small-cell-lung-cancer-time-results-from-the-phase-2b-part-of-a-randomised-double-blind-placebo-controlled-phase-2b3-trial","status":"publish","type":"post","link":"https:\/\/www.transgene.com\/fr\/tg4010-immunotherapy-and-first-line-chemotherapy-for-advanced-non-small-cell-lung-cancer-time-results-from-the-phase-2b-part-of-a-randomised-double-blind-placebo-controlled-phase-2b3-trial\/","title":{"rendered":"TG4010 immunotherapy and first-line chemotherapy for advanced non-small-cell lung cancer (TIME): results from the phase 2b part of a randomised, double-blind, placebo-controlled, phase 2b\/3 trial"},"content":{"rendered":"<p><a href=\"http:\/\/www.thelancet.com\/journals\/lanonc\/article\/PIIS1470-2045(15)00483-0\/abstract\"><\/a><br \/>\nElisabeth Quoix, et al.<br \/>\nThe Lancet Oncology, December 2015, 17: 212\u201323 \u2013 <a href=\"http:\/\/www.thelancet.com\/journals\/lanonc\/article\/PIIS1470-2045(15)00483-0\/abstract\" target=\"_blank\" rel=\"noopener noreferrer\"><strong>Download the article<\/strong><\/a><br \/>\n<em>Publication<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Elisabeth Quoix, et al. The Lancet Oncology, December 2015, 17: 212\u201323 \u2013 Download the article Publication<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_coblocks_attr":"","_coblocks_dimensions":"","_coblocks_responsive_height":"","_coblocks_accordion_ie_support":"","_uag_custom_page_level_css":"","footnotes":""},"categories":[181,144,5,16],"tags":[],"class_list":["post-16210","post","type-post","status-publish","format-standard","hentry","category-other-fr","category-144","category-publication-fr","category-tg4010-fr","entry"],"uagb_featured_image_src":{"full":false,"thumbnail":false,"medium":false,"medium_large":false,"large":false,"1536x1536":false,"2048x2048":false,"post-thumbnail":false},"uagb_author_info":{"display_name":"alcyon","author_link":"https:\/\/www.transgene.com\/fr\/author\/alcyon\/"},"uagb_comment_info":0,"uagb_excerpt":"Elisabeth Quoix, et al. The Lancet Oncology, December 2015, 17: 212\u201323 \u2013 Download the article Publication","_links":{"self":[{"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/posts\/16210","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/comments?post=16210"}],"version-history":[{"count":1,"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/posts\/16210\/revisions"}],"predecessor-version":[{"id":38806,"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/posts\/16210\/revisions\/38806"}],"wp:attachment":[{"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/media?parent=16210"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/categories?post=16210"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/tags?post=16210"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}